-
1دورية أكاديمية
المؤلفون: Skipper, Mette Tiedemann, Birkebæk, Niels, Jensen, Rikke Beck, Rank, Cecilie Utke, Tuckuviene, Ruta, Wehner, Peder Skov, Lambine, Trine Lise, Hørlyck, Arne, Schmiegelow, Kjeld, Frandsen, Thomas Leth, Andrés-Jensen, Liv, Albertsen, Birgitte Klug
المصدر: Skipper , M T , Birkebæk , N , Jensen , R B , Rank , C U , Tuckuviene , R , Wehner , P S , Lambine , T L , Hørlyck , A , Schmiegelow , K , Frandsen , T L , Andrés-Jensen , L & Albertsen , B K 2024 , ' Pancreas-related persisting sequelae in ALL survivors with a history of asparaginase-associated pancreatitis : A part of the ALL-STAR study ' , European journal of haematology , vol. 112 , no. 6 , pp. 944-956 . https://doi.org/10.1111/ejh.14189Test
مصطلحات موضوعية: acute lymphoblastic leukemia, chemotherapy, long-term cancer survivors, pediatric hematology/oncology, sequelae, treatment outcome, Cancer Survivors, Follow-Up Studies, Humans, Middle Aged, Child, Preschool, Infant, Male, Case-Control Studies, Young Adult, Adult, Antineoplastic Agents/adverse effects, Female, Asparaginase/adverse effects, Survivors, Pancreas/pathology, Adolescent, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Pancreatitis/diagnosis
وصف الملف: application/pdf
العلاقة: https://portal.findresearcher.sdu.dk/da/publications/322bb998-4185-4dd0-8079-2f2b0b6280f5Test
الإتاحة: https://doi.org/10.1111/ejh.14189Test
https://portal.findresearcher.sdu.dk/da/publications/322bb998-4185-4dd0-8079-2f2b0b6280f5Test
https://findresearcher.sdu.dk/ws/files/259855969/European_J_of_Haematology_-_2024_-_Skipper_-_Pancreas_related_persisting_sequelae_in_ALL_survivors_with_a_history_of.pdfTest -
2دورية أكاديمية
المؤلفون: Colunga Biancatelli, Ruben M. L., Solopov, Pavel A., Day, Tierney, Gregory, Betsy, Osei-nkansah, Michael, Dimitropoulou, Christiana, Catravas, John D.
المصدر: Bioelectrics Publications
مصطلحات موضوعية: Animals, Antineoplastic agents - adverse effects, Apoptosis, Benzamides, Chlorine gas, Chronic illnesses, Chronic lung injury, Collagen, Drug approval, Endothelial cells - metabolism, Ethylenediaminetetraacetic acid, Geranylgeranyl acetone, Gefitinib, Gefitinib - adverse effects, Growth factor beta, Growth factors, Health aspects, Heat shock proteins, HSP70, HSP70 heat-shock proteins - metabolism, HSP90 heat-shock proteins - metabolism, HSP90 inhibitors, Humans, Hydrochloric acid, Hydrochloric acid - toxicity, Index medicus, Inflammation, Kinases, Lung injury - chemically induced, Lung injury - drug therapy
وصف الملف: application/pdf
العلاقة: https://digitalcommons.odu.edu/bioelectrics_pubs/366Test; https://digitalcommons.odu.edu/context/bioelectrics_pubs/article/1371/viewcontent/Biancatelli_2024_HSP70isaCriticalRegulatorofHSP90OCR.pdfTest
الإتاحة: https://doi.org/10.3390/ijms25031920Test
https://digitalcommons.odu.edu/bioelectrics_pubs/366Test
https://digitalcommons.odu.edu/context/bioelectrics_pubs/article/1371/viewcontent/Biancatelli_2024_HSP70isaCriticalRegulatorofHSP90OCR.pdfTest -
3دورية أكاديمية
المؤلفون: Sacher, Adrian, LoRusso, Patricia, Patel, Manish R, Miller, Wilson H, Garralda, Elena, Forster, Martin D, Santoro, Armando, Falcon, Alejandro, Kim, Tae Won, Paz-Ares, Luis, Bowyer, Samantha, de Miguel, Maria, Han, Sae-Won, Krebs, Matthew G, Lee, Jong-Seok, Cheng, Michael L, Arbour, Kathryn, Massarelli, Erminia, Choi, Yoonha, Shi, Zhen, Mandlekar, Sandhya, Lin, Mark T, Royer-Joo, Stephanie, Chang, Julie, Dharia, Neekesh V, Schutzman, Jennifer L, Desai, Jayesh
المساهمون: Freres, Pierre
المصدر: New England Journal of Medicine, 389 (8), 710 - 721 (2023-08-24)
مصطلحات موضوعية: Antineoplastic Agents, KRAS protein, human, Proto-Oncogene Proteins p21(ras), Enzyme Inhibitors, Humans, Mutation, Proto-Oncogene Proteins p21(ras)/genetics, Administration, Oral, Antineoplastic Agents/administration & dosage, Antineoplastic Agents/adverse effects, Antineoplastic Agents/therapeutic use, Carcinoma, Non-Small-Cell Lung/drug therapy, Carcinoma, Non-Small-Cell Lung/genetics, Colorectal Neoplasms/drug therapy, Colorectal Neoplasms/genetics, Lung Neoplasms/drug therapy, Lung Neoplasms/genetics, Enzyme Inhibitors/administration & dosage, Enzyme Inhibitors/adverse effects, Enzyme Inhibitors/therapeutic use, Cancer, Gastroenterology, Gastrointestinal Tract Cancer, Genetics, Hematology/Oncology, Lung Cancer, Pulmonary/Critical Care, Pulmonary/Critical Care General, Treatments in Oncology, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Lung Neoplasms, Medicine (all), General Medicine, Human health sciences, Oncology, Sciences de la santé humaine, Oncologie
العلاقة: http://www.nejm.org/doi/pdf/10.1056/NEJMoa2303810Test; urn:issn:0028-4793; urn:issn:1533-4406
الوصول الحر: https://orbi.uliege.be/handle/2268/311523Test
-
4دورية أكاديمية
المساهمون: Jang Ho Lee, Kim, Eun Young
مصطلحات موضوعية: Antineoplastic Agents* / adverse effects, Carcinoma, Non-Small-Cell Lung* / drug therapy, Non-Small-Cell Lung* / genetics, Non-Small-Cell Lung* / pathology, ErbB Receptors / genetics, Humans, Lung Neoplasms* / drug therapy, Lung Neoplasms* / genetics, Lung Neoplasms* / pathology, Mutation, Protein Kinase Inhibitors / adverse effects, Republic of Korea, EGFR T790M, Non–small cell lung cancer, Osimertinib, Real-world efficacy
العلاقة: CANCER RESEARCH AND TREATMENT; J00453; OAK-2022-11161; OAK-2022-11162; https://ir.ymlib.yonsei.ac.kr/handle/22282913/193643Test; T202301273; CANCER RESEARCH AND TREATMENT, Vol.55(1) : 112-122, 2023-01
الإتاحة: https://doi.org/10.4143/crt.2022.381Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/193643Test -
5دورية أكاديمية
المساهمون: Yuna Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Myung Ji Goh, Wonseok Kang, Seung Up Kim, Kim, Do Young
مصطلحات موضوعية: Antineoplastic Agents* / adverse effects, Carcinoma, Hepatocellular* / pathology, Humans, Liver Neoplasms* / pathology, Middle Aged, Nivolumab / adverse effects, Phenylurea Compounds / adverse effects, Sorafenib / adverse effects, Treatment Failure
العلاقة: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY; J00821; OAK-2022-10721; OAK-2022-10722; OAK-2022-10723; OAK-2022-10724; OAK-2022-10725; OAK-2022-10726; OAK-2022-10727; OAK-2022-10728; https://ir.ymlib.yonsei.ac.kr/handle/22282913/193516Test; https://journals.lww.com/eurojgh/Fulltext/2023/02000/Sorafenib_versus_nivolumab_after_lenvatinib.7.aspxTest; T202300160; EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, Vol.35(2) : 191-197, 2023-02
الإتاحة: https://doi.org/10.1097/MEG.0000000000002466Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/193516Test
https://journals.lww.com/eurojgh/Fulltext/2023/02000/Sorafenib_versus_nivolumab_after_lenvatinib.7.aspxTest -
6دورية أكاديمية
المؤلفون: Heipertz, Anna-Elisa, Pajtler, Kristian W, Pfaff, Elke, Schramm, Kathrin, Blattner-Johnson, Mirjam, Milde, Till, Jones, Barbara C, Zuliani, Cecilia, Hutter, Caroline, Lohi, Olli, Kattamis, Antonis, Dachowska-Kalwak, Iwona, Nilsson, Anna, Gerber, Nicolas U, Langenberg, Karin P S, Goemans, Bianca, Zwaan, C Michel, Molenaar, Jan J, Jäger, Natalie, Dirksen, Uta, Witt, Ruth, Pfister, Stefan M, Jones, David T W, Kopp-Schneider, Annette, Witt, Olaf, van Tilburg, Cornelis M
المساهمون: Afd Pharmaceutics, Pharmaceutics
مصطلحات موضوعية: Animals, Humans, Child, Adolescent, Antineoplastic Agents/adverse effects, Proto-Oncogene Proteins B-raf/genetics, Precision Medicine, Neoplasm Recurrence, Local/drug therapy, Receptor Protein-Tyrosine Kinases, TOR Serine-Threonine Kinases, Carcinoma, Mitogen-Activated Protein Kinase Kinases, Mammals, Taverne
وصف الملف: application/pdf
-
7دورية أكاديمية
المؤلفون: van de Vlasakker, V.C.J., Lurvink, R.J., Wassenaar, E.C., Rauwerdink, P., Bakkers, C., Rovers, K.P., Bonhof, C.S., Burger, J.W.A., Wiezer, M.J., Boerma, D., Nienhuijs, S.W., Mols, F., de Hingh, I.H.J.T.
المصدر: van de Vlasakker , V C J , Lurvink , R J , Wassenaar , E C , Rauwerdink , P , Bakkers , C , Rovers , K P , Bonhof , C S , Burger , J W A , Wiezer , M J , Boerma , D , Nienhuijs , S W , Mols , F & de Hingh , I H J T 2023 , ' Comparing patient reported abdominal pain between patients treated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) and primary colorectal cancer surgery ' , Scientific Reports , vol. 13 , 20458 ....
مصطلحات موضوعية: Abdominal Pain/etiology, Aerosols, Antineoplastic Agents/adverse effects, Colorectal Neoplasms/drug therapy, Humans, Oxaliplatin/therapeutic use, Patient Reported Outcome Measures, Peritoneal Neoplasms/secondary, Prospective Studies
العلاقة: https://research.tilburguniversity.edu/en/publications/06d23188-b41b-48dc-b672-03cec4facdd1Test
الإتاحة: https://doi.org/10.1038/s41598-023-47510-0Test
https://research.tilburguniversity.edu/en/publications/06d23188-b41b-48dc-b672-03cec4facdd1Test
http://www.scopus.com/inward/record.url?scp=85177572153&partnerID=8YFLogxKTest -
8دورية أكاديمية
المؤلفون: Mfumbilwa, Zakile A, Wilschut, Janneke A, Simons, Martijn J H G, Ramaekers, Bram, Joore, Manuela, Retèl, Valesca, der Welle, Christine M Cramer-van, Schramel, Franz M N H, van de Garde, Ewoudt M W, Coupé, Veerle M H
المساهمون: Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology, PECP – Centre for Clinical Therapeutics
مصطلحات موضوعية: Humans, Antineoplastic Agents/adverse effects, Netherlands, Cost-Benefit Analysis, Lung Neoplasms/drug therapy, Carcinoma, Non-Small-Cell Lung/drug therapy, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Competing risks, Multicenter, Tyrosine kinase inhibitors, Survival outcomes, Cost-effectiveness analysis, Chemotherapy, Pembrolizumab, Simulation, Immunotherapy, 1st-line therapy, General
وصف الملف: application/pdf
-
9دورية أكاديمية
المؤلفون: Hellfritzsch, Maja, Henriksen, Jakob Nørgaard, Holt, Marianne Ingerslev, Grove, Erik Lerkevang
المصدر: Hellfritzsch , M , Henriksen , J N , Holt , M I & Grove , E L 2024 , ' Drug-Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants ' , Seminars in Thrombosis and Hemostasis , vol. 50 , no. 3 , pp. 489-498 . https://doi.org/10.1055/s-0043-1762596Test
مصطلحات موضوعية: anticoagulants, cancer, drug interactions, venous thromboembolism, Administration, Oral, Humans, Dabigatran/therapeutic use, Anticoagulants/therapeutic use, Rivaroxaban/therapeutic use, Antineoplastic Agents/adverse effects, Neoplasms/complications, Venous Thromboembolism/etiology
الإتاحة: https://doi.org/10.1055/s-0043-1762596Test
https://pure.au.dk/portal/en/publications/0a2565de-8a37-4227-b2c2-785b14d95303Test
http://www.scopus.com/inward/record.url?scp=85187542295&partnerID=8YFLogxKTest -
10دورية أكاديمية
المساهمون: Filip Janku, Seung-Hoon Beom, Yong Wha Moon, Tae Won Kim, Young G Shin, Dong-Seok Yim, Gun Min Kim, Hyo Song Kim, Sun Young Kim, Jae-Ho Cheong, Young Woo Lee, Barb Geiger, Sanghee Yoo, Archie Thurston, Dean Welsch, Marc S Rudoltz, Sun Young Rha, Beom, Seung Hoon
مصطلحات موضوعية: Antineoplastic Agents* / adverse effects, Biguanides / therapeutic use, Dose-Response Relationship, Drug, Humans, Maximum Tolerated Dose, Nausea / chemically induced, Neoplasms* / metabolism, Oxidative Phosphorylation, Biguanide, Cancer, Clinical trial, IM156, Protein complex I inhibitor
وصف الملف: application/pdf
العلاقة: INVESTIGATIONAL NEW DRUGS; J01184; OAK-2022-08283; OAK-2022-08284; OAK-2022-08285; OAK-2022-08286; https://ir.ymlib.yonsei.ac.kr/handle/22282913/192217Test; T202204900; INVESTIGATIONAL NEW DRUGS, Vol.40(5) : 1001-1010, 2022-10
الإتاحة: https://doi.org/10.1007/s10637-022-01277-9Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/192217Test